News Focus
News Focus
Followers 92
Posts 7487
Boards Moderated 1
Alias Born 09/18/2009

Re: tscott4 post# 23718

Thursday, 12/24/2020 11:07:12 PM

Thursday, December 24, 2020 11:07:12 PM

Post# of 44330
The DSMB and the FDA are not blinded to the interim results. The FDA had to have a legitimate basis to approve the resumption of leronlimab, and to provide open label usage instructions to be followed by EIND patients' doctors.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today